what-when-how
In Depth Tutorials and Information
unknown. It has been suggested that FKBP65 has a chap-
erone effect on LH2, but a direct interaction has not been
established. Further research on this molecule will shed
light on our understanding of how collagen normally
matures to produce a functional matrix for bone, tendon
and ligaments.
in Dachshunds with osteogenesis imperfecta. PLoS Genet
2009;5:e1000579.
[17] Ishikawa Y, Vranka J, Wirz J, Nagata K, Bächinger HP. The
rough endoplasmic reticulum-resident FK506-binding protein
FKBP65 is a molecular chaperone that interacts with collagens.
J Biol Chem 2008;283:31584-90.
[18] Alanay Y, Avaygan H, Camacho N, Utine G, Boduroglu K,
Aktas D, et al. Mutations in the gene encoding the RER protein
FKBP65 cause autosomal-recessive osteogenesis imperfecta. Am
J Hum Genet 2010;86:551-9.
[19] Shaheen R, Al-Owain M, Sakati N, Alzayed ZS, Alkuraya FS.
FKBP10 and Bruck syndrome: phenotypic heterogeneity or call
for reclassiication? Am J Hum Genet 2010;87:306.
[20] Kelley BP, Malfait F, Bonafe L, Baldridge D, Homan E, Symoens S,
et al. Mutations in FKBP10 cause recessive osteogenesis imperfecta
and Bruck syndrome. J Bone Miner Res 2011;26:666-72.
[21] Alanay Y, Krakow D. Response to Shaheen et  al. Am J Hum
Genet 2010;87:308.
[22] Barnes A, Cabral W, Weis M, Makareeva E, Merta E, Leikin S,
et al. Absence of FKBP10 in recessive type XI OI leads to dimin-
ished collagen cross-linking and reduced collagen deposition in
extracellular matrix. Hum Mutat 2012;33:1589-98.
[23] Hasegawa K. Genetic basis for skeletal disease. Osteogenesis
imperfecta and genetic abnormalities. Clin Calcium 2010;20:1190.
[24] Schwarze U, Cundy T, Pyott SM, Christiansen HE, Hegde MR,
Bank RA, et al. Mutations in FKBP10, which result in Bruck syn-
drome and recessive forms of osteogenesis imperfecta, inhibit
the hydroxylation of telopeptide lysines in bone collagen. Hum
Mol Genet 2013;22:1-17.
[25] Shaheen R, Al-Owain M, Faqeih E, Al-Hashmi N, Awaji A,
Al-Zayed Z, et  al. Mutations in FKBP10 cause both Bruck syn-
drome and isolated osteogenesis imperfecta in humans. Am J
Med Genet A 2011;155:1448-52.
[26] Steinlein OK, Aichinger E, Trucks H, Sander T. Mutations in
FKBP10 can cause a severe form of isolated osteogenesis imper-
fecta. BMC Med Genet 2011;12:152.
[27] Venturi G, Monti E, Dalle Carbonare L, Corradi M, Gandini A,
Valenti MT, et  al. A novel splicing mutation in FKBP10 causing
osteogenesis imperfecta with a possible mineralization defect.
Bone 2012;50:343-9.
[28] Viljoen D, Versfeld G, Beighton P. Osteogenesis imperfecta with
congenital joint contractures (Bruck syndrome). Clin Genet 1989;
36:122-6.
[29] Hyry M, Lantto J, Myllyharju J. Missense mutations that cause
Bruck syndrome affect enzymatic activity, folding, and oligomer-
ization of lysyl hydroxylase 2. J Biol Chem 2009;284:30917-24.
[30] Alanay Y, Bank RA, Campos-Xavier AB, Zankl A,
Superti-Furga A, Bonafé L. Phenotypic and molecular character-
ization of Bruck syndrome (osteogenesis imperfecta with con-
tractures of the large joints) caused by a recessive mutation in
PLOD2. Am J Med Genet A 2004;131:115-20.
[31] Blacksin M, Pletcher BA, David M. Osteogenesis imperfecta with
joint contractures: Bruck syndrome. Pediatr Radiol 1998;28:117-9.
[32] Brady A, Patton M. Osteogenesis imperfecta with arthrogryposis
multiplex congenita (Bruck syndrome) - evidence for possible
autosomal recessive inheritance. Clin Dysmorphol 1997;6:329-36.
[33] Brenner R, Vetter U, Stöss H, Müller P, Teller W. Defective col-
lagen ibril formation and mineralization in osteogenesis imper-
fecta with congenital joint contractures (Bruck syndrome). Eur J
Pediatr 1993;152:505-8.
[34] Breslau-Siderius E, Engelbert R, Pals G, Van der Sluijs J. Bruck
syndrome: a rare combination of bone fragility and multiple con-
genital joint contractures. J Pediatr Orthop B 1998;7:35-8.
[35] Steinmann B, Royce PM. Bruck Syndrome. Connective Tissue and
Its Heritable Disorders: Molecular, Genetic, and Medical Aspects,
2nd ed. 2003;1115-7.
References
[1] Harding MW, Galat A, Uehling DE, Schreiber SL. A receptor for
the immuno-suppressant FK 506 is a cis-trans peptidyl-prolyl
isomerase. Nature 1989;341:758-60.
[2] Kang CB, Hong Y, Dhe-Paganon S, Yoon HS. FKBP family
proteins: immunophilins with versatile biological functions.
Neurosignals 2008;16:318-25.
[3] Solassol J, Mange A, Maudelonde T. FKBP family proteins as
promising new biomarkers for cancer. Curr Opin Pharmacol 2011;
11:320-5.
[4] Liu J, Farmer Jr JD, Lane WS, Friedman J, Weissman I, Schreiber SL.
Calcineurin is a common target of cyclophilin-cyclosporin A and
FKBP-FK506 complexes. Cell 1991;66:807-15.
[5] Patterson CE, Gao J, Rooney AP, Davis EC. Genomic organization
of mouse and human 65 kDa FK506-binding protein genes and
evolution of the FKBP multigene family. Genomics 2002;79:881-9.
[6] Nigam S, Jin Y, Jin M, Bush K, Bierer B, Burakoff S. Localization
of the FK506-binding protein, FKBP 13, to the lumen of the
endoplasmic reticulum. Biochem J 1993;294:511.
[7] Nakamura T, Yabe D, Kanazawa N, Tashiro K, Sasayama S,
Honjo T. Molecular cloning, characterization, and chromosomal
localization of FKBP23, a novel FK506-binding protein with
Ca 2+ -binding ability. Genomics 1998;54:89-98.
[8] Shadidy M, Caubit X, Olsen R, Seternes OM, Moens U,
Krauss S. Biochemical analysis of mouse FKBP60, a novel mem-
ber of the FKPB family. Biochim Biophys Acta - Gene Struct Expr
1999;1446:295-307.
[9] Coss MC, Winterstein D, Raymond CS, Simek SL. Molecular
cloning, DNA sequence analysis, and biochemical characteriza-
tion of a novel 65-kDa FK506-binding protein (FKBP65). J Biol
Chem 1995;270:29336-41.
[10]
Patterson CE, Abrams WR, Wolter NE, Rosenbloom J, Davis EC.
Developmental regulation and coordinate reexpression of FKBP65
with extracellular matrix proteins after lung injury suggest a spe-
cialized function for this endoplasmic reticulum immunophilin.
Cell Stress Chaperones 2005;10:285.
[11]
Patterson CE, Schaub T, Coleman EJ, Davis EC. Developmental
regulation of FKBP65 an ER-localized extracellular matrix
binding-protein. Mol Biol Cell 2000;11:3925-35.
[12]
Zeng B, MacDonald JR, Bann J, Beck K, Gambee JE, Boswell BA,
et al. Chicken FK506-binding protein, FKBP65, a member of the
FKBP family of peptidylprolyl cis-trans isomerases, is only par-
tially inhibited by FK506. Biochem J 1998;330:109.
[13]
Nagata K. Hsp47: a collagen-speciic molecular chaperone.
Trends Biochem Sci 1996;21:23-6.
[14]
Nagai N, Hosokawa M, Itohara S, Adachi E, Matsushita T,
Hosokawa N, et al. Embryonic lethality of molecular chaperone
hsp47 knockout mice is associated with defects in collagen bio-
synthesis. J Cell Biol 2000;150:1499-506.
[15]
Christiansen HE, Schwarze U, Pyott SM, AlSwaid A,
Al Balwi M, Alrasheed S, et al. Homozygosity for a missense muta-
tion in SERPINH1 , which encodes the collagen chaperone protein
HSP47, results in severe recessive osteogenesis imperfecta. Am J
Hum Genet 2010;86:389-98.
[16]
Drögemüller C, Becker D, Brunner A, Haase B, Kircher P,
Seeliger F, et  al. A missense mutation in the SERPINH1 gene
Search WWH ::




Custom Search